Smart wearable glucose patch market seen reaching $5.09 billion by 2030

The smart wearable glucose patch market is projected to more than double from 2025 to 2030 as diabetes rates rise and demand grows for noninvasive monitoring tools. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Smart wearable glucose patches could make diabetes management easier by reducing the need for finger-prick testing. - The market’s growth reflects rising diabetes risk, wider use of continuous glucose monitoring, and stronger demand for remote care tools. - The category is moving toward real-time, connected monitoring that supports faster treatment decisions and better self-care.

What happened: - The smart wearable glucose patch market is projected to rise from $2.22 billion in 2025 to $2.62 billion in 2026. - The market is forecast to reach $5.09 billion by 2030. - The Business Research Company published the market report on Aug. 30, 2026. - The report is available as a free sample and as the full report.

The details: - The market is expected to grow at a compound annual growth rate of 18.3% from 2025 to 2026. - It is forecast to grow at an 18.0% CAGR from 2026 to 2030. - The report says growth has been driven by diabetes prevalence, demand for alternatives to traditional finger-prick testing, wearable biosensor advances, expanded chronic disease monitoring, and greater use of patient self-care. - The forecast assumes continued progress in remote diabetes management, AI-powered glucose analytics, telehealth integration, reimbursement policies for continuous glucose monitoring devices, and preventive diabetes care. - The report highlights non-invasive glucose monitoring, continuous sensing, real-time data transmission, extended-wear patches, and digital self-management tools as key trends. - A smart wearable glucose patch is a flexible biosensor that tracks glucose through the skin without finger-prick blood samples. - The patches measure glucose in interstitial fluid and wirelessly send readings to connected devices. - The technology is designed to provide continuous, real-time glucose monitoring with greater comfort and convenience. - The report says this can help users maintain better glucose control and make more informed lifestyle and treatment decisions. - In June 2024, the UK National Health Service reported that more than 549,000 new people in England were identified as at risk for type 2 diabetes in 2023. - The NHS said the total number of people with pre-diabetes registered with general practitioners in England rose to 3,615,330 in 2023 from 3,065,825 in 2022. - That increase was nearly 20% year over year. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The 2026 report package also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and trend analysis.

Between the lines: - The market outlook suggests glucose monitoring is shifting from episodic testing to always-on, connected care. - Reimbursement and telehealth support could matter as much as hardware improvements because they affect adoption. - The strongest regional growth in Asia-Pacific may reflect both rising diabetes burden and expanding access to digital health tools.

What's next: - Market growth will likely depend on how quickly noninvasive monitoring, AI analytics, and telehealth features reach broader commercial use. - Expanded reimbursement for continuous glucose monitoring devices could accelerate adoption. - Prevention-focused diabetes care may become a bigger driver as more patients are identified earlier in the disease pathway.